Pseudomonas aeruginosa is a dominant pathogen in people with cystic fibrosis (CF)
contributing to morbidity and mortality. Its tremendous ability to adapt greatly facilitates its …

Cystic fibrosis (CF) is one of the most common life-shortening genetic diseases in
Caucasians. Due to abnormal accumulation of mucus, respiratory failure caused by chronic …

Pseudomonas aeruginosa is a major pathogen in the lungs of cystic fibrosis (CF) patients.
However, it is now recognised that a diverse microbial community exists in the airways …

Despite standard treatment with systemic corticosteroids and/or antifungal triazoles, a
substantial proportion of patients with allergic bronchopulmonary aspergillosis (ABPA) …

Drug resistance represents a great concern among people with cystic fibrosis (CF), due to
the recurrent and prolonged antibiotic therapy they should often undergo. Among Multi Drug …

Introduction: Bronchiectasis is a chronic endobronchial suppurative disease characterized
by irreversibly dilated bronchi damaged by repeated polymicrobial infections and …

Many cystic fibrosis (CF) airway infections are considered to be polymicrobial and microbe–
microbe interactions may play an important role in disease pathology. Pseudomonas …

Airway inflammation and chronic lung infections in cystic fibrosis (CF) patients are mostly
caused by bacteria, eg Pseudomonas aeruginosa (PA). The role of fungi in the CF lung is …

Pseudomonas aeruginosa is one of the most dominant pathogens in cystic fibrosis (CF)
airway disease and contributes to significant inflammation, airway damage, and poorer …

Fungi serve as a biological scaffold for bacterial attachment. In some specialized
interactions, the bacteria will invade the fungal host, which in turn provides protection and …